STOCK TITAN

Viatris Inc. to Participate in the 2021 RBC Capital Markets Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Viatris Inc. (NASDAQ: VTRS) will participate in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on May 18, 2021, at 9:10 a.m. ET. CEO Michael Goettler and CFO Sanjeev Narula will discuss the company and answer questions. A live webcast will be available at investor.viatris.com, with an archived version accessible later. Formed in November 2020 from Mylan and Pfizer's Upjohn business, Viatris serves over 165 countries and offers a diverse portfolio of over 1,400 approved medicines.

Positive
  • None.
Negative
  • None.

PITTSBURGH, April 30, 2021 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021. Chief Executive Officer Michael Goettler and Chief Financial Officer Sanjeev Narula will answer questions about the company at 9:10 a.m. ET.

Interested parties can access a live webcast of the event at investor.viatris.com. An archived version also will be available following the live event and can be accessed at the same location for a limited time. 

About Viatris 
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare company, empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020 through the combination of Mylan and Pfizer's Upjohn business, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, a growing portfolio of biosimilars and a variety of over-the-counter consumer products. With a global workforce of approximately 45,000, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisIncLinkedIn and YouTube

Viatris Logo (PRNewsfoto/Viatris Inc.)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/viatris-inc-to-participate-in-the-2021-rbc-capital-markets-global-healthcare-conference-301280901.html

SOURCE Viatris Inc.

FAQ

When is Viatris participating in the RBC Capital Markets Global Healthcare Conference?

Viatris will participate in the RBC Capital Markets Global Healthcare Conference on May 18, 2021.

Who will represent Viatris at the healthcare conference?

CEO Michael Goettler and CFO Sanjeev Narula will represent Viatris at the conference.

What time is Viatris's session at the conference?

Viatris's session is scheduled for 9:10 a.m. ET on May 18, 2021.

Where can I watch the Viatris conference session?

You can watch the Viatris conference session live at investor.viatris.com.

What is the origin of Viatris?

Viatris was formed in November 2020 through the merger of Mylan and Pfizer's Upjohn business.

How many countries does Viatris serve?

Viatris serves over 165 countries and territories worldwide.

How many approved medicines does Viatris offer?

Viatris offers a portfolio of over 1,400 approved medicines.

Viatris Inc.

NASDAQ:VTRS

VTRS Rankings

VTRS Latest News

VTRS Stock Data

15.53B
1.19B
0.41%
82.73%
2.05%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
CANONSBURG